Detalhe da pesquisa
1.
EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
J Hepatol;
61(2): 325-32, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24704591
2.
Two-dimensional dynamic evaluation of natural killer cell-mediated lysis of adherent target cells.
Methods Enzymol;
631: 289-304, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31948553
3.
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
J Immunother Cancer;
8(2)2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32912923
4.
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.
Front Immunol;
10: 661, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30984204
5.
CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes.
Cancer Immunol Res;
7(2): 208-218, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30514793
6.
Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.
Front Immunol;
8: 683, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28659921
7.
Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib.
Cancer Immunol Res;
5(7): 582-593, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28576831